BerandaGNGBF • OTCMKTS
add
Getinge AB
Tutup sebelumnya
$24,48
Rentang tahun
$18,54 - $24,48
Kapitalisasi pasar
56,07 M SEK
Volume Rata-Rata
21,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 8,23 M | 4,52% |
Biaya operasional | 2,83 M | 3,47% |
Penghasilan bersih | 566,00 jt | 28.200,00% |
Margin laba bersih | 6,88 | 22.833,33% |
Penghasilan per saham | 2,42 | 8,04% |
EBITDA | 1,27 M | 14,98% |
Tarif pajak efektif | 27,09% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,85 M | 27,04% |
Total aset | 56,79 M | -4,74% |
Total liabilitas | 27,41 M | -5,95% |
Total ekuitas | 29,38 M | — |
Saham yang beredar | 272,37 jt | — |
Harga terhadap nilai buku | 0,23 | — |
Tingkat pengembalian aset | 4,35% | — |
Tingkat pengembalian modal | 6,08% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 566,00 jt | 28.200,00% |
Kas dari operasi | 1,08 M | 59,41% |
Kas dari investasi | -292,00 jt | 90,61% |
Kas dari pembiayaan | 193,00 jt | -91,81% |
Perubahan kas bersih | 902,00 jt | 2.104,44% |
Arus kas bebas | 631,75 jt | -73,13% |
Tentang
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the Chairman of the Board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Didirikan
1904
Situs
Karyawan
11.794
